Esophageal Cancer

Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy
Zhen Zhang, Tianchen Luo, Meng Yan, Haixia Shen, Kaiyi Tao, Jian Zeng, Jingping Yuan, Min Fang, Jian Zheng, Inigo Bermejo, Andre Dekker, Dirk De Ruysscher, Leonard Wee, Wencheng Zhang, Youhua Jiang, Yongling Ji

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e011149; DOI: 10.1136/jitc-2024-011149
Hypoxia inhibits the iMo/cDC2/CD8+ TRMs immune axis in the tumor microenvironment of human esophageal cancer
Chuanqiang Wu, Huan Yu, Fuxiang Liang, Xiancong Huang, Bin Jiang, Zhiling Lou, Yafei Liu, Zixiang Wu, Qi Wang, Hong Shen, Ming Chen, Pin Wu, Ming Wu

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008889; DOI: 10.1136/jitc-2024-008889
CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1–CXCR2 induced NETs
Gan Xiong, Zhi Chen, Qianwen Liu, Fang Peng, Caihua Zhang, Maosheng Cheng, Rongsong Ling, Shuang Chen, Yu Liang, Demeng Chen, Qimin Zhou

Journal for ImmunoTherapy of Cancer May 2024, 12 (5) e008662; DOI: 10.1136/jitc-2023-008662
Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial
Ning Jiang, Jingyuan Zhang, Zhen Guo, Yinan Wu, Lijun Zhao, Cheng Kong, Xue Song, Lingling Gu, Yang Zhao, Si Li, Xia He, Binhui Ren, Xiangzhi Zhu, Ming Jiang

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008229; DOI: 10.1136/jitc-2023-008229
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
Kohei Shitara, Taroh Satoh, Satoru Iwasa, Kensei Yamaguchi, Kei Muro, Yoshito Komatsu, Tomohiro Nishina, Taito Esaki, Jun Hasegawa, Yasuyuki Kakurai, Emi Kamiyama, Tomoko Nakata, Kota Nakamura, Hayato Sakaki, Ichinosuke Hyodo

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 219; DOI: 10.1186/s40425-019-0679-9
Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma
Tomonori Yaguchi, Kenji Morii, Satoshi Serada, Tetsuji Naka, Yutaka Kawakami

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P125; DOI: 10.1186/2051-1426-3-S2-P125
Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
Brendan D Curti, Emmanuel Akporiaye, Kim Sutcliffe, Keith S Bahjat, Yoshinobu Koguchi, Julie Cramer, Walter Urba

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P148; DOI: 10.1186/2051-1426-3-S2-P148
In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
Hiroaki Ikeda, Shinichi Kageyama, Naoko Imai, Yoshihiro Miyahara, Mikiya Ishihara, Naoyuki Katayama, Hirofumi Yoshioka, Daisuke Tomura, Ikuei Nukaya, Junichi Mineno, Kazuto Takesako, Hiroshi Shiku

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) O3; DOI: 10.1186/2051-1426-1-S1-O3
Immunotherapy targeting esophageal cancer stem cells
Dongli Yue, Hongzheng Ren, Lan Huang, Yi Zhang

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P178; DOI: 10.1186/2051-1426-1-S1-P178
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
H Shiku, H Ikeda, Y Miyahara, M Ishihara, N Katayama, D Tomura, I Nukaya, J Mineno, K Takesako, S Kageyama

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P45; DOI: 10.1186/2051-1426-2-S2-P45

Log in using your username and password

Main menu

Log in using your username and password

You are here

Esophageal Cancer